Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

COPD and Asthma Devices Market by Inhalers Type Drug powder, Metered Dose, Soft Mist and Nebulizers

Thursday, February 23, 2017 23:00
% of readers think this story is Fact. Add your two cents.

(Before It's News)

COPD and asthma devices, also known as pulmonary drug delivery devices, are used as a permanent treatment or rescue therapy for respiratory diseases and other related ailments. It is the most advanced mode of drug administration in which the drug is directly delivered to the lungs to provide a systemic effect. COPD and asthma have significant shares in the global respiratory diseases market. According to the Global Initiative for Asthma (GINA), around 300 million people across the world suffer from asthma every year. COPD, being the 3rd leading cause for death, led to the death of 3 million people in 2013.

Enquire about report: http://www.bigmarketresearch.com/report-enquiry/152427

The world COPD and asthma devices market is expected to reach $41,355.2 million by 2022. The major factors driving the market growth include increasing awareness for respiratory diseases, such as asthma and emphysema, and rising incidence of respiratory diseases caused due to cigarette consumption. The growth of the market would be boosted due to increase in healthcare expenditure, growth in the use of automation in healthcare industry, and rapid adoption of advanced medical solutions. Currently, most of healthcare practitioners and pulmonary diseases specialists prefer a combination of a drug and a device, for instance inhaler and nebulizer, owing to its fast and effective outcome. However, the market growth could be hindered due to high cost associated with nebulizers, side effects occurring due to excessive dosage, and lack of awareness regarding drug inhalation.

Request sample of report @ http://www.bigmarketresearch.com/request-sample/152427

The world COPD and asthma devices market is segmented based on product device type and geography. Based on the product device type, the market is segmented into inhalers and nebulizers. Inhalers segment is projected to grow at a CGAR of 5.3% during the study period. Furthermore, the inhalers segment includes dry powder inhalers (DPIs), metered dose inhalers (MDIs), and soft mist inhalers (SMIs). The nebulizers segment includes compressor nebulizers, ultrasonic nebulizers, and mesh nebulizers. Based on geography, the market is categorized into North America, Europe, Asia-Pacific, and LAMEA. These regions are further analyzed on the basis of respective countries. Within Europe region, Germany, France and U.K. accounted for more than 40% of market share in 2015.

Enquire here for customization of report @ http://www.bigmarketresearch.com/request-for-customization/152427

About Big Market Research:      

Big Market Research uniqueness lies in its highly ethical reports at economical rates because we value your relationship and growth more than money. Your growth is our aim.

Our strength is in our research analysts who with their proactive approach can source best and correct information which can be detrimental in organizations success. We follow six sigma standards leaving no scope for error.

Contact Big Market Research:

Direct Contact: + 1-503-894-6022
Toll Free: + 1-800-910-6452
Email: help@bigmarketresearch.com
Web: http://www.bigmarketresearch.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.